Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 298(7): 102018, 2022 07.
Article in English | MEDLINE | ID: mdl-35526563

ABSTRACT

Hyperekplexia is a rare neurological disorder characterized by exaggerated startle responses affecting newborns with the hallmark characteristics of hypertonia, apnea, and noise or touch-induced nonepileptic seizures. The genetic causes of the disease can vary, and several associated genes and mutations have been reported to affect glycine receptors (GlyRs); however, the mechanistic links between GlyRs and hyperekplexia are not yet understood. Here, we describe a patient with hyperekplexia from a consanguineous family. Extensive genetic screening using exome sequencing coupled with autozygome analysis and iterative filtering supplemented by in silico prediction identified that the patient carries the homozygous missense mutation A455P in GLRB, which encodes the GlyR ß-subunit. To unravel the physiological and molecular effects of A455P on GlyRs, we used electrophysiology in a heterologous system as well as immunocytochemistry, confocal microscopy, and cellular biochemistry. We found a reduction in glycine-evoked currents in N2A cells expressing the mutation compared to WT cells. Western blot analysis also revealed a reduced amount of GlyR ß protein both in cell lysates and isolated membrane fractions. In line with the above observations, coimmunoprecipitation assays suggested that the GlyR α1-subunit retained coassembly with ßA455P to form membrane-bound heteromeric receptors. Finally, structural modeling showed that the A455P mutation affected the interaction between the GlyR ß-subunit transmembrane domain 4 and the other helices of the subunit. Taken together, our study identifies and validates a novel loss-of-function mutation in GlyRs whose pathogenicity is likely to cause hyperekplexia in the affected individual.


Subject(s)
Hyperekplexia , Receptors, Glycine , Humans , Hyperekplexia/genetics , Infant, Newborn , Muscle Rigidity , Mutation , Mutation, Missense , Receptors, Glycine/genetics
3.
Neuropharmacology ; 140: 86-99, 2018 09 15.
Article in English | MEDLINE | ID: mdl-30009837

ABSTRACT

A-type K+ channels restrain the spread of incoming signals in tufted and apical dendrites of pyramidal neurons resulting in strong compartmentalization. However, the exact subunit composition and functional significance of K+ channels expressed in small diameter proximal dendrites remain poorly understood. We focus on A-type K+ channels expressed in basal and oblique dendrites of cortical layer 3 pyramidal neurons, in ex vivo brain slices from young adult mice. Blocking putative Kv4 subunits with phrixotoxin-2 enhances depolarizing potentials elicited by uncaging RuBi-glutamate at single dendritic spines. A concentration of 4-aminopyridine reported to block Kv1 has no effect on such responses. 4-aminopyridine and phrixotoxin-2 increase supralinear summation of glutamatergic potentials evoked by synchronous activation of clustered spines. The effect of 4-aminopyridine on glutamate responses is simulated in a computational model where the dendritic A-type conductance is distributed homogeneously or in a linear density gradient. Thus, putative Kv4-containing channels depress excitatory inputs at single synapses. The additional recruitment of Kv1 subunits might require the synchronous activation of multiple inputs to regulate the gain of signal integration.


Subject(s)
Glutamic Acid/physiology , Neocortex/cytology , Pyramidal Cells/physiology , Shal Potassium Channels/physiology , 4-Aminopyridine/pharmacology , Action Potentials/physiology , Animals , Dendrites/physiology , Dendritic Spines/physiology , Excitatory Postsynaptic Potentials/physiology , Female , Glutamic Acid/analogs & derivatives , Glutamic Acid/pharmacology , Male , Mice , Models, Neurological , Neocortex/physiology , Organometallic Compounds/pharmacology , Shal Potassium Channels/antagonists & inhibitors , Spider Venoms/pharmacology
4.
Mol Cell Neurosci ; 92: 82-92, 2018 10.
Article in English | MEDLINE | ID: mdl-30044951

ABSTRACT

We have synthesized a novel small molecule based on the pyrrolidinone-containing core structure of clausenamide, which is a candidate anti-dementia drug. The synthetic route yielded multi-gram quantities of an isomeric racemate mixture in a short number of steps. When tested in hippocampal slices from young adult rats the compound enhanced AMPA receptor-mediated signalling at mossy fibre synapses, and potentiated inward currents evoked by local application of l-glutamate onto CA3 pyramidal neurons. It facilitated the induction of mossy fibre LTP, but the magnitude of potentiation was smaller than that observed in untreated slices. The racemic mixture was separated and it was shown that only the (-) enantiomer was active. Toxicity analysis indicated that cell lines tolerated the compound at concentrations well above those enhancing synaptic transmission. Our results unveil a small molecule whose physiological signature resembles that of a potent nootropic drug.


Subject(s)
Nootropic Agents/pharmacology , Pyrrolidinones/pharmacology , Receptors, AMPA/metabolism , Synaptic Transmission/drug effects , Animals , CA3 Region, Hippocampal/drug effects , CA3 Region, Hippocampal/physiology , Glutamic Acid/metabolism , Long-Term Potentiation/drug effects , Male , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/physiology , Nootropic Agents/chemistry , Pyrrolidinones/chemistry , Rats , Rats, Sprague-Dawley
5.
Nat Commun ; 6: 8038, 2015 Sep 03.
Article in English | MEDLINE | ID: mdl-26333769

ABSTRACT

The potassium-chloride co-transporter KCC2, encoded by SLC12A5, plays a fundamental role in fast synaptic inhibition by maintaining a hyperpolarizing gradient for chloride ions. KCC2 dysfunction has been implicated in human epilepsy, but to date, no monogenic KCC2-related epilepsy disorders have been described. Here we show recessive loss-of-function SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epilepsy of infancy with migrating focal seizures (EIMFS). Decreased KCC2 surface expression, reduced protein glycosylation and impaired chloride extrusion contribute to loss of KCC2 activity, thereby impairing normal synaptic inhibition and promoting neuronal excitability in this early-onset epileptic encephalopathy.


Subject(s)
Chlorides/metabolism , Epilepsies, Partial/genetics , Neural Inhibition/genetics , Neurons/metabolism , Symporters/genetics , Animals , Child , Child, Preschool , HEK293 Cells , Humans , Immunoblotting , Infant , Male , Mutation , Patch-Clamp Techniques , Pedigree , Sequence Analysis, DNA , Symporters/metabolism , Zebrafish , Zebrafish Proteins , K Cl- Cotransporters
6.
J Physiol ; 592(1): 67-86, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-24081159

ABSTRACT

Zinc actions on synaptic transmission span the modulation of neurotransmitter receptors, transporters, activation of intracellular cascades and alterations in gene expression. Whether and how zinc affects inhibitory synaptic signalling in the dentate gyrus remains largely unexplored. We found that mono- and di-synaptic GABAergic inputs onto dentate granule cells were reversibly depressed by exogenous zinc application and enhanced by zinc chelation. Blocking T-type Ca(2+) channels prevented the effect of zinc chelation. When recording from dentate fast-spiking interneurones, zinc chelation facilitated T-type Ca(2+) currents, increased action potential half-width and decreased spike threshold. It also increased the offset of the input-output relation in a manner consistent with enhanced excitability. In granule cells, chelation of zinc reduced the time window for the integration of glutamatergic inputs originating from perforant path synapses, resulting in reduced spike transfer. Thus, zinc-mediated modulation of dentate interneurone excitability and GABA release regulates information flow to local targets and hippocampal networks.


Subject(s)
Calcium Channels, T-Type/metabolism , Dentate Gyrus/physiology , GABAergic Neurons/metabolism , Inhibitory Postsynaptic Potentials , Interneurons/metabolism , Zinc/metabolism , Animals , Chelating Agents/pharmacology , Dentate Gyrus/cytology , Dentate Gyrus/metabolism , Ethylenediamines/pharmacology , GABAergic Neurons/drug effects , GABAergic Neurons/physiology , Glutamic Acid/metabolism , Interneurons/drug effects , Interneurons/physiology , Rats , Rats, Sprague-Dawley , Reaction Time , Zinc/deficiency
7.
Front Neural Circuits ; 6: 112, 2012.
Article in English | MEDLINE | ID: mdl-23316138

ABSTRACT

Dentate granule cells process information from the enthorinal cortex en route to the hippocampus proper. These neurons have a very negative resting membrane potential and are relatively silent in the slice preparation. They are also subject to strong feed-forward inhibition. Their unmyelinated axon or mossy fiber ramifies extensively in the hilus and projects to stratum lucidum where it makes giant en-passant boutons with CA3 pyramidal neurons. There is compelling evidence that mossy fiber boutons express presynaptic GABA(A) receptors, which are commonly found in granule cell dendrites. There is also suggestive evidence for the presence of other ionotropic receptors, including glycine, NMDA, and kainate receptors, in mossy fiber boutons. These presynaptic receptors have been proposed to lead to mossy fiber membrane depolarization. How this phenomenon alters the excitability of synaptic boutons, the shape of presynaptic action potentials, Ca(2+) influx and neurotransmitter release has remained elusive, but high-resolution live imaging of individual varicosities and direct patch-clamp recordings have begun to shed light on these phenomena. Presynaptic GABA(A) and kainate receptors have also been reported to facilitate the induction of long-term potentiation at mossy fiber-CA3 synapses. Although mossy fibers are highly specialized, some of the principles emerging at this connection may apply elsewhere in the CNS.

SELECTION OF CITATIONS
SEARCH DETAIL
...